CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CarboMed aims to evaluate the potential of targeting the glycosylation patterns of cancer cells as a novel treatment strategy. By disrupting the protective carbohydrate coat of cancer cells, the project seeks to inhibit tumor growth and spread, paving the way for future clinical applications.
CarboMed will assess the commercial viability of targeting cancer cell glycosylation as a next-generation therapeutic strategy to treat cancer in the clinic.
Carbohydrates (glycans) coat the cell of every organism.
The glycosylation pattern of cancer cells is, however, very different from that of healthy cells and is associated with aggressive and invasive forms of cancers.
By combining our knowledge on carbohydrate chemistry and cancer immunology we targeted the cancer-cell protecting carbohydr…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
